{"id":"W3087285392","doi":"10.1371/journal.pmed.1003222","title":"Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study","year":2020,"lang":"en","type":"article","venue":"PLoS Medicine","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Children's Hospital","funders":"National Institute of Child Health and Human Development; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Parent Project Muscular Dystrophy; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Astellas Pharma; Eunice Kennedy Shriver National Institute of Child Health and Human Development; European Commission; PTC Therapeutics; Sarepta Therapeutics; FibroGen; Pfizer; National Institute on Disability and Rehabilitation Research; National Institute on Disability, Independent Living, and Rehabilitation Research; Eli Lilly and Company","keywords":"Duchenne muscular dystrophy; Interim analysis; Interim; Medicine; Muscular dystrophy; Randomized controlled trial; Physical therapy; Physical medicine and rehabilitation; Internal medicine; Political science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0134243,0.001536131,0.004656942,0.0007537172,0.0006876857,0.001647635,0.001066159,0.002101133,0.004790627],"category_scores_gemma":[0.01051153,0.0005350592,0.004800472,0.0006361096,0.001048041,0.001383513,0.0006932383,0.00272001,0.001097291],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008448894,"about_ca_system_score_gemma":0.00147659,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004597733,"about_ca_topic_score_gemma":0.0007555568,"domain_scores_codex":[0.9929207,0.004637963,0.000482046,0.000576726,0.0006683184,0.0007142853],"domain_scores_gemma":[0.9843273,0.005857988,0.004500927,0.001795513,0.001694529,0.001823752],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9674069,0.008942699,0.005525286,0.0004476869,0.002700508,0.0000941099,0.0001089815,0.0003642942,0.002187642,0.00004288005,0.000524139,0.01165474],"study_design_scores_gemma":[0.5464073,0.4043995,0.04029144,0.0001218428,0.004435875,0.0001844417,0.0001103944,0.0008957246,0.001523076,0.0002104811,0.001356892,0.00006304902],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883003,0.003010877,0.001106235,0.0002775258,0.0002005223,0.003913217,0.001858315,0.0001031394,0.00122983],"genre_scores_gemma":[0.9873291,0.0007939591,0.002198298,0.0005292919,0.000294315,0.005153139,0.001841054,0.00003117001,0.001829583],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0134243,"threshold_uncertainty_score":0.07099539,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04221909287974521,"score_gpt":0.3289326659827698,"score_spread":0.2867135731030246,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}